Vasomedical, Inc. operates in the Electromedical equipment sector. Vasomedical, Inc. (Vasomedical) is engaged in designing, manufacturing, marketing and supporting enhanced external counterpulsation (EECP) systems based on its technology indicated by the United States Food and Drug Administration (FDA) for use in cases of stable or unstable angina, congestive heart failure (CHF), acute myocardial infarction (heart attack, (MI)) and cardiogenic shock. The EECP therapy is a non-invasive, outpatient treatment of diseases of the cardiovascular system. The Company provides hospitals, clinics and physician private practices with EECP equipment, treatment guidance, and a staff training and equipment maintenance program designed to provide optimal patient outcomes. It also offers accessories and consumables to EECP therapy providers. The Company has FDA clearance to market its EECP therapy for use in the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and cardiogenic shock. In our complete report available for purchase the company is compared to: Positron Corporation, PLC Systems Inc. and Aradigm Corporation.